Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group-Reference-Cited by-同舟云学术

Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group

Published:2010-12 Issue:12 Volume:5 Page:2008-2011
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Jalal Shadia,Bedano Pablo,Einhorn Lawrence,Bhatia Sumeet,Ansari Rafat,Bechar Naftali,Koneru Karuna,Govindan Ramaswamy,Wu Jingwei,Yu Menggang,Schneider Bryan,Hanna Nasser

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

2. Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study;Ettinger;J Clin Oncol,1995

3. Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group;Kirschling;Am J Clin Oncol,1999

4. A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer;Smit;Br J Cancer,1998

5. Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer;Sandler;N Engl J Med,2006

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Cell Lung Cancer: Emerging Targets and Strategies for Precision Therapy;Cancers;2023-08-08

2. Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy;Seminars in Cancer Biology;2022-11

3. Personalized treatment of extensive stage small cell lung cancer: A case report and literature review;Frontiers in Oncology;2022-08-11

4. Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma;Thoracic Cancer;2021-09-06

5. Pathogenesis and therapeutic strategy in platinum resistance lung cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-08